ISBRA 2006 World Congress on Alcohol Research

Session Details

Advances in pharmacotherapy for alcohol dependence

Sunday, 10 September 2006 11:00 -12:30

Ballroom 3

Chair Jonathan Chick University of EdinburghUnited Kingdom
Co-Chair Raymond F Anton Center for Drug and Alcohol ProgramsUnited States

Naltrexone versus acamprosate for alcohol dependence in Australia: a randomised controlled trial
  • Kirsten Morley, 6Drug Health Services, Royal Prince Alfred Hospital, Camperdown, Australia
  • Studies of nalmefene in alcoholics
  • Raymond F Anton, Center for Drug and Alcohol Programs, Medical University of South Carolina, United States
  • Using Acamprosate in the USA
  • Barbara J Mason, The Scripps Research Institute, United States
  • Developments in long-acting naltrexone preparations
  • James C Garbutt, Department of Psychiatry, United States
  • Methodology and technology: Results from recent disulfiram treatment outcome studies
  • Jonathan Chick, University of Edinburgh, United Kingdom
  • Published on Thursday, 7 September 2006 by the Professional Conference Organiser